Rheumatoid arthritis

Window of opportunity for anti-TNF in early inflammatory arthritis

Three quarters of patients with early inflammatory arthritis who respond to a combination of infliximab and methotrexate can expect to have a second drug-free year in remission, according to European research. The Definitive Intervention in New Onset Rheumatoid Arthritis (DINORA) trial randomised 90 patients with synovial swelling in at least two joints for two to ...

Already a member?

Login to keep reading.

© 2021 the limbic